CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
CA 19-9 as a Marker for Gastrointestinal Cancers: A Review - M J Duffy, 1998
Tumour markers
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
CA 19.9 - Pancreatic Cancer Marker – Beacon Health Screening Centre
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Predictive value of multiple serum tumor markers | CMAR
CA 19-9 as a Serum Biomarker in Cancer | SpringerLink
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
CA 19-9 Antigen - an overview | ScienceDirect Topics
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Tumor Marker CA 19-9 for Assessing Pancreatic Cancer Response - Cancer Therapy Advisor
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
CA-19-9 - Diagnostic Kit
Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
PDF) CA 19-9 in pancreatic cancer: Retrospective evaluation of patients with suspicion of pancreatic cancer
CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube
Tumor markers in clinical practice Colorectal - CEA Hepatocellular ... | GrepMed
Health Screening – Raised Cancer Markers CEA, Ca 19-9 and aFP
Markedly elevated CA19-9 associated with benign ovarian cyst and ascites | BMJ Case Reports
